News

TipRanks on MSN14h

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy

Shares in biopharmaceutical company Precigen (PGEN) rocketed higher today after the U.S. Food and Drug Administration gave ...

Precigen: This Billion-Dollar Approval Is Still Undervalued

Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...
Fierce Pharma1d

Precigen scores FDA nod for first-ever treatment for HPV-related disorder

For the first time, the FDA has approved a treatment for recurrent respiratory papillomatosis (RRP), a rare, chronic disease ...

Why Is Precigen Stock Surging On Friday?

Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials.

Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial

The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad.
TipRanks on MSN1d

Precigen trading halted, news pending

EDT Precigen (PGEN) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday

Evolv Technologies reported a quarterly loss of 2 cents per share which beat the analyst consensus estimate of a loss of 4 ...